Cabot Corporation

NYSE:CBT

Chemicals - Specialty

Basic Materials
$74.03 +1.09%

+$0.96 today

Market cap
$3.80B
Beta
0.83
P/E (TTM)
16.3
EPS (TTM)
$5.48
Dividend yield
2.04%
52W Low $58.33High $90.08

Volume 0.53M

Average 0.43M

CBT Deferred Tax Liabilities

Taxes owed in future periods because of timing differences between accounting and tax rules.

Cabot CorporationNYSE: CBT

Deferred Tax Liabilities · Q3 FY2026 · quarter ended Jun 2026

Deferred tax liabilities falls 10.0% from a year ago

Deferred tax liabilities stood at $36M at the end of Q3 FY2026, down 10.0% from a year earlier and down 10.0% from the prior quarter. Over 3 fiscal years it compounded at -15.7% a year.

Context

  • Deferred tax liabilities amounted to 0.9% of total assets at the end of Q3 FY2026, down 0.1 pp from a year earlier.
  • Deferred tax liabilities increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether deferred tax liabilities keeps falling in the next quarterly balance sheet after a -10.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$36M-10.0% QoQ
Last fiscal yearSep 2025
$39M-7.1% YoY
Year agoJun 2025
$40M-10.0% since
Deferred Tax Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-10.0%——
1 year-7.1%——
3-year CAGR-15.7%——
5-year CAGR——
10-year CAGR——

Deferred Tax Liabilities history

USD · from the balance sheet

Latest · FY2025
39M USD
Year-over-year change
-7.1%
4-year CAGR
-14.5%

Deferred Tax Liabilities vs competitors

How CBT compares with its peers on the latest reported figures

  • Peers report in different currencies, so deferred tax liabilities is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -10.0% is the 5th highest of 10, against a peer median of -10.1%.
  • Deferred tax liabilities amounts to 0.9% of total assets for CBT, versus a peer median of 2.3%.
CBT Competitors
Deferred Tax Liabilities for CBT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SSLSasol LimitedJun 2026ZAR 2.74B ZAR-21.1%—0.8%
CECelanese CorporationJun 2026$458M USD-34.9%-25.6%2.1%
MEOHMethanex CorporationJun 2026$330.73M USD-7.1%+12.5%4.6%
KNFKnife River CorporationJun 2026$296.47M USD+15.1%+17.9%7.1%
AVNTAvient CorporationSep 2026$276.7M USD-10.1%-5.9%4.7%
PRMPerimeter Solutions, Inc.Jun 2026$78M USD-45.4%-33.9%2.4%
CBTCabot CorporationJun 2026$36M USD-10.0%-15.7%0.9%
HWKNHawkins, Inc.Sep 2026$26.14M USD+18.0%+4.4%2.6%
SXTSensient Technologies CorporationJun 2026$13.44M USD-10.9%-5.1%0.6%
WDFCWD-40 CompanyAug 2026$8.58M USD-8.5%-5.9%1.7%
FULH.B. Fuller CompanyAug 2026$0 USD——0.0%
Peer median (excluding CBT) —-10.1%-5.5%2.3%

Competitors are the stored peer set for CBT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Cash & Equivalents168M206M238M223M258M
Short-term Investments00000
Net Receivables645M836M695M733M671M
Inventory523M664M585M552M504M
Other Current Assets00108M0106M
Total Current Assets1.43B1.82B1.63B1.61B1.54B
Property, Plant & Equipment (Net)1.38B1.27B1.41B1.53B1.71B
Goodwill140M129M134M133M134M
Intangible Assets100M63M60M53M55M
Long-term Investments40M20M20M23M16M
Tax Assets53M45M180M216M180M
Other Non-current Assets172M178M172M172M180M
Total Non-current Assets1.88B1.71B1.98B2.13B2.28B
Total Assets3.31B3.53B3.6B3.74B3.82B
Account Payables480M533M438M495M459M
Short-term Debt445M354M182M67M274M
Tax Payables35M44M40M43M35M
Deferred Revenue00000
Other Current Liabilities75M66M55M167M77M
Total Current Liabilities1.15B1.11B822M772M957M
Long-term Debt717M1.09B1.09B1.15B856M
Deferred Tax Liabilities73M65M50M42M39M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities195M151M147M69M173M
Total Non-current Liabilities1.07B1.39B1.38B1.37B1.15B
Total Liabilities2.22B2.49B2.2B2.15B2.11B
Common Stock57M56M55M54M53M
Retained Earnings1.16B1.28B1.57B1.73B1.84B
Accumulated OCI(289M)(439M)(362M)(360M)(335M)
Other Stockholders Equity00000
Minority Interest143M134M143M165M155M
Total Equity1.09B1.03B1.41B1.59B1.71B
Total Debt1.25B1.53B1.36B1.33B1.22B
Net Debt1.08B1.32B1.12B1.11B957M

Cabot Corporation

NYSE:CBT

Intrinsic Alpha fair value

Locked

Current Price

$74.03

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.